Verbeek, R., Boyer, M., Boekholdt, S. M., Hovingh, G. K., Kastelein, J. J., Wareham, N., . . . Arsenault, B. J. (2016). Carriers of the PCSK9 R46L variant are characterized by an anti-atherogenic lipoprotein profile assessed by nuclear magnetic resonance spectroscopy. Arterioscler Thromb Vasc Biol.
Citação norma ChicagoVerbeek, Rutger, Marjorie Boyer, S. Matthijs Boekholdt, G. Kees Hovingh, John J.P Kastelein, Nicholas Wareham, Kay-Tee Khaw, and Benoit J. Arsenault. "Carriers of the PCSK9 R46L Variant Are Characterized By an Anti-atherogenic Lipoprotein Profile Assessed By Nuclear Magnetic Resonance Spectroscopy." Arterioscler Thromb Vasc Biol 2016.
Citação norma MLAVerbeek, Rutger, et al. "Carriers of the PCSK9 R46L Variant Are Characterized By an Anti-atherogenic Lipoprotein Profile Assessed By Nuclear Magnetic Resonance Spectroscopy." Arterioscler Thromb Vasc Biol 2016.